Publikationen von Foell, Juergen

Mohrez, Morad, Troeger, Anja, Kleinschmidt, Katharina, Hanafee Alali, Tarek, Jakob, Marcus, Brosig, Andreas Michael , Hähnel, Viola , Kietz, Silke, Offner, Robert , Burkhardt, Ralph , Corbacioglu, Selim , Ahrens, Norbert und Foell, Juergen (2023) Feasibility of peripheral blood stem cell collection from sickle cell trait donors with an intensified G‐CSF regimen. European Journal of Haematology.

Kleinschmidt, Katharina, Troeger, Anja, Foell, Juergen, Jakob, Marcus und Corbacioglu, Selim (2022) Successful Use of Interferon-Gamma for Refractory Disseminated Candida Tropicalis Infection in a Pediatric Patient with Acute Myeloid Leukemia and Heterozygous CARD9 Mutation. Archives of Clinical and Medical Case Reports 6 (5), S. 626-629.

Knapp, Selina, Brosig, Andreas, Troeger, Anja, Kleinschmidt, Katharina, Offner, Robert, Corbacioglu, Selim, Burkhardt, Ralph , Foell, Juergen und Ahrens, Norbert (2021) Granulocyte transfusions made with modified fluid gelatin in pediatric and adolescent patients with prolonged neutropenia. Transfusion 62, S. 306-315.

Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K., Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W. , Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M., Locatelli, Franco, Mapara, Markus Y., de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay , Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H., Wall, Donna, Yen, Angela und Corbacioglu, Selim (2021) CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine 384 (3), S. 252-260. Volltext nicht vorhanden.

Foell, Juergen, Kleinschmidt, Katharina, Troeger, Anja, Turowski, Petra, Spachtholz, Rainer, Ahrens, Norbert , Brosig, Andreas-Michael , Evert, Matthias, Schmidt, René, Wolff, Daniel, Edinger, Matthias, Eyrich, Matthias, Handgretinger, Rupert, Ellinger, Susanne und Corbacioglu, Selim (2020) A Phase II Stratified Trial to Assess Haploidentical tdepleted Stem Cell Transplantation in Patients with Sickle Cell Disease with no Available Sibling Donor. Bone marrow transplantation 55 (Suppl), S. 440. Volltext nicht vorhanden.

Kleinschmidt, Katharina, Foell, Juergen, Pfirstinger, Beatrix, Troeger, Anja, Mayr, Agnes, Dibbern, Pauline, Brosig, Andreas , Ahrens, Norbert und Corbacioglu, Selim (2020) Haploidentical T-Cell Depleted HSCT Represents a Safe Therapeutic Alternative to MSD Transplantation in Patients with Transfusion-dependent ß-Thalassemia Major. Bone marrow transplantation 55 (Suppl), S. 161-162. Volltext nicht vorhanden.

Foell, Juergen, Wolff, Daniel, Troeger, Anja, Kleinschmidt, Katharina, Pfirstinger, Beatrix, Edinger, Matthias, Aslanidis, Charalampos, Hofmann, Petra, Holler, Ernst, Ahrens, Norbert , Ellinger, Susanne, Schmidt, René, Herr, Wolfgang und Corbacioglu, Selim (2019) Phase 2 international, multicentre trial to assess haploidentical Aß T-cell depleted stem cell transplantation in patients with sickle cell disease with no available sibling donor. Bone marrow transplantation 54 (Suppl), S. 356-357. Volltext nicht vorhanden.

Foell, Juergen, Schulte, Johannes H , Pfirstinger, Beatrix, Troeger, Anja, Wolff, Daniel, Edinger, Matthias, Hofmann, Petra, Aslanidis, Charalampos, Lang, Peter, Holler, Ernst, Eggert, Angelika und Corbacioglu, Selim (2019) Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease. Bone Marrow Transplantation 54 (11), S. 1859-1867. Volltext nicht vorhanden.